TAK logo

TAK R&D Expense Growth

Latest reported-15.84%
TAK Quarterly R&D Growth (QoQ) (0.00% → -15.84%)
High-resolution chart · PNG

TAK r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-15.8431%
11.4992%
10.4732%
12.2252%
-33.3838%
26.9147%
-3.0593%
4.2152%
-13.9863%
4.5229%
1.8674%
13.0299%
1.1165%
-7.8366%
13.2888%
7.3381%
-0.0146%
11.879%
-2.4483%
7.4461%
8.1129%
-3.638%
-0.5002%
10.6121%
-23.3208%
13.5279%
8.1165%
-2.8828%
-16.168%
79.968%
-2.5231%
10.4216%
-18.9408%
8.8495%
2.7151%
4.9149%
-14.4807%
23.208%
-4.751%
-1.4814%
-16.8197%
-0.5361%
15.1066%
-0.7519%
-39.0445%
43.3199%
13.9437%
8.2603%
-27.2923%
24.38%
8.4341%
-1.167%
-16.3636%
20.5743%
1.4486%
-3.9035%
0%
-100%
15.4211%
6.1873%
0%
-100%
5.9985%
-0.0499%
0%
-100%
4.2198%
9.0138%
0%
-100%
-34.4469%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.